MarketPulse
R

$RANI

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Rani Therapeutics Raises $20M via Direct Offering as Clinical-Stage Biotech Seeks Growth Capital

Rani Therapeutics raises $20M at $1.07/share via registered direct offering led by sovereign wealth fund, with expected May 2026 close.
RANIcapital raiseregistered direct offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Rani Therapeutics Names Pharma Veteran Høiland as Head of Strategy

Rani Therapeutics appoints pharma veteran Jesper Høiland as Head of Strategy, bringing 30+ years of experience in obesity and metabolic disease from roles at Novo Nordisk, Radius Health, and Ascendis Pharma.
RANIsemaglutidepipeline strategy